Genetic tests

VERACITY is one of the most advanced non-invasive prenatal tests (NIPT).
It is a next-generation test that allows the detection of chromosomal abnormalities in the fetus at an early stage of pregnancy.  

Ventrilla is a fast genetic test that detects inherited risks of cardiovascular diseases. It analyzes 292 genes and helps identify conditions such as arrhythmias or cardiomyopathies at an early stage. You will receive your result within 3–5 weeks, and the price includes a free consultation with a clinical geneticist.

Ventrilla is a genetic test that detects changes in genes related to cardiovascular diseases. There are 7 different panels focused on detecting conditions such as: arrhythmia, aortopathy, cardiomyopathy, familial hypercholesterolemia, RASopathy, pulmonary hypertension, and a panel dedicated to diagnosing congenital heart defects.

The PGx Preventive Pharmacogenetic Panel is a genetic test that allows for the selection of safer and more effective medications tailored to your genetic profile. The test covers 25 genes, including 16 key pharmacogenes, and helps minimize the risk of adverse drug reactions while optimizing treatment. The test result is useful throughout your life, as your genetic profile remains unchanged.

Rodinia is a genetic test that allows the detection of changes in genes associated with infertility in both women and men. The male panel includes the analysis of 40 genes and the evaluation of sex chromosomes X and Y, including Y chromosome microdeletion. The female panel analyzes the full coding sequence of 55 genes and evaluates sex chromosome aneuploidies, including changes in number, structural changes, and mosaicism.

Rodinia is a genetic test that detects changes in genes associated with female infertility. The panel includes 55 genes and sex chromosome aneuploidies, including changes in their number, structure, and mosaicism.

Rodinia test for thrombophilia and neonatal thrombocytopenia (NAIT) detects genetic variants that increase the risk of miscarriages, thrombotic events, and alloimmune neonatal thrombocytopenia (NAIT). 

Rodinia is a genetic test that allows the detection of changes in genes associated with infertility in both women and men. The male panel includes the analysis of 40 genes and the evaluation of sex chromosomes X and Y, including Y chromosome microdeletion. The female panel analyzes the full coding sequence of 55 genes and evaluates sex chromosome aneuploidies, including changes in number, structural changes, and mosaicism.

Rodinia is a genetic test that detects changes in genes associated with male infertility. The panel includes 40 genes and detects abnormalities in sex chromosomes (X and Y), including Y chromosome microdeletions.